Mouse model of oropharyngeal candidiasis
- PMID: 22402633
- PMCID: PMC3671943
- DOI: 10.1038/nprot.2012.011
Mouse model of oropharyngeal candidiasis
Abstract
Oropharyngeal candidiasis is a frequent cause of morbidity in patients with defects in cell-mediated immunity or saliva production. Animal models of this infection are important for studying disease pathogenesis and evaluating vaccines and antifungal therapies. Here we describe a simple mouse model of oropharyngeal candidiasis. Mice are rendered susceptible to oral infection by injection with cortisone acetate and then inoculated by placing a swab saturated with Candida albicans sublingually. This process results in a reproducible level of infection, the histopathology of which mimics that of pseudomembranous oropharyngeal candidiasis in humans. By using this model, data are obtained after 5-9 d of work.
Figures
References
-
- Sangeorzan JA, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994;97:339–346. - PubMed
-
- Rhodus NL, Bloomquist C, Liljemark W, Bereuter J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren’s syndrome. J Otolaryngol. 1997;26:300–305. - PubMed
-
- Willis AM, et al. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med. 1999;16:675–679. - PubMed
-
- Arribas JR, et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. Aids. 2000;14:979–985. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
